1989
DOI: 10.1182/blood.v74.7.2519.2519
|View full text |Cite
|
Sign up to set email alerts
|

Priming of human neutrophils with N-formyl-methionyl-leucyl- phenylalanine by a calcium-independent, pertussis toxin-insensitive pathway

Abstract: Resting neutrophils may be “primed” to augmented effector function, eg, superoxide (O2-) production in the respiratory burst, upon a second stimulation with a variety of soluble agonists including formylated methionyl-leucyl-phenylalanine (FMLP) and phorbol myristate acetate (PMA). At priming concentrations of FMLP (5 x 10(-9) mol/L) that did not initiate O2- generation, two metabolic activities were noted: (1) approximately a threefold increase in the baseline intracellular calcium (Ca++i) level, that was not… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1990
1990
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…The increases in chemoattractant induced Ca 2+ transients may reflect an activated or primed state of the neutrophils. The phenomena of an enhanced stimulus induced response of granulocytes after pre-incubation with low-concentration of various agonists that do not evoke any detectable response is referred to as priming [10]. Priming may account for alterations in calcium signalling observed in granulocytes of patients with rheumatoid arthritis [6].…”
Section: Discussionmentioning
confidence: 99%
“…The increases in chemoattractant induced Ca 2+ transients may reflect an activated or primed state of the neutrophils. The phenomena of an enhanced stimulus induced response of granulocytes after pre-incubation with low-concentration of various agonists that do not evoke any detectable response is referred to as priming [10]. Priming may account for alterations in calcium signalling observed in granulocytes of patients with rheumatoid arthritis [6].…”
Section: Discussionmentioning
confidence: 99%
“…Depending on the timepoint or receptor type, VIP may have different effects on developing cDCs, inducing an inhibitory or immunogenic/mature cDC phenotype [ 376 , 377 , 378 ]. VIP primes the oxidative response of neutrophils to formyl-methionyl-leucyl-phenylalanine (FMLP) and phorbol myristate acetate (PMA) [ 379 , 380 ]. VIP has autocrine functions in mast cells that produce VIP and histamine through the classical IgE-mediated pathway, and VIP can also stimulate the release of histamine by mast cells, leading to inflammatory effects [ 381 , 382 ].…”
Section: Neuropeptides and Their Receptors In The Corneamentioning
confidence: 99%